CARA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CARA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.
Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.
For the Biotechnology subindustry, Cara Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Cara Therapeutics's Short Interest distribution charts can be found below:
* The bar in red indicates where Cara Therapeutics's Short Interest falls into.
Christopher Posner | director | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL, STAMFORD CT 06902 |
Joana Goncalves | officer: Chief Medical Officer | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL, STAMFORD CT 06902 |
Scott Terrillion | officer: Sec'y; Chief Compliance & G.C. | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL, STAMFORD CT 06902 |
Helen M Boudreau | director | 200 TECHNOLOGY SQUARE, 4TH FLOOR, CAMBRIDGE MA 02139 |
Menzaghi Frederique Ph.d. | officer: VP-Research & Development | C/O CARA THERAPEUTICS, INC., 1 PARROTT DRIVE, SHELTON CT 06484 |
Ryan D Maynard | officer: Chief Financial Officer | RIGEL PHARMACEUTICALS, INC., 1180 VETERANS BLVD., SOUTH SAN FRANCISCO CA 94080 |
Moltke Lisa Von | director | C/O SERESTHERAPEUTICS, INC., 200 SIDNEY STREET, CAMBRIDGE MA 02139 |
Martin Vogelbaum | director | 675 ALMANOR AVE, SUNNYVALE CA 94085 |
Csl Ltd | 10 percent owner | |
Jeffrey L. Ives | director | C/O CARA THERAPEUTICS, INC., 1 PARROTT DRIVE, SHELTON CT 06484 |
Bains Harrison M Jr | director | |
Thomas Charles Reilly | officer: Chief Financial Officer | C/O CARA THERAPEUTICS, INC., 4 STAMFORD PLAZA, 107 ELM STREET, STAMFORD CT 06902 |
Vifor Fresenius Medical Care Renal Pharma Ltd. | 10 percent owner | RECHENSTRASSE 37, CH-9014, ST. GALLEN V8 9014 |
Vifor (international) Ltd | 10 percent owner | RECHENSTRASSE 37, ST. GALLEN V8 9000 |
Vifor Pharma Ltd. | 10 percent owner | UNTERMATTWEG 8, BERNE V8 CH-3027 |
From GuruFocus
By GuruFocus Research • 03-02-2024
By GuruFocus Research • 03-02-2024
By GuruFocus Research • 03-02-2024
By GuruFocus Research • 03-02-2024
By GuruFocus Research • 03-02-2024
By GuruFocus Research • 03-05-2024
By GuruFocus Research • 03-02-2024
By GuruFocus Research • 03-02-2024
By Marketwired • 06-12-2024
By GuruFocus Research • 03-02-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.